Breast cancer patients who are overweight or obese might benefit less from treatment with docetaxel, a common chemotherapy drug, than lean patients. An international team of researchers based this conclusion on a retrospective analysis of data from a large clinical trial.

An Imperial researcher discussed a trial giving UK COVID-19 patients blood plasma from people who have recovered from coronavirus, in a recent talk. Professor Anthony Gordon, Chair in Anaesthesia and Critical Care at Imperial College London and a Consultant in Intensive Care Medicine at Imperial College Healthcare NHS Trust, is leading a trial to investigate whether convalescent plasma transfusions improve the speed of recovery and chances of survival for patients with COVID-19.

In a new  Yale Cancer Center  (YCC) study, researchers have demonstrated that a higher percentage of women with breast cancer had their disease diagnosed at an early stage in states with expanded Medicaid coverage through the Affordable Care Act (ACA).

Sydney researchers are taking an innovative approach to designing potential COVID-19 vaccines - using a tuberculosis vaccine to deliver components of the SARS-CoV-2 virus. Early results from pre-clinical testing in mice are promising.

The researcher developing a potential new coronavirus vaccine said the technology behind it could also be used for future pandemics, in a recent talk. Professor Robin Shattock, from the Department of Infectious Diseases at Imperial College London, is leading the development of a candidate vaccine.

Stanford researchers tested a new insulin drug in diabetic pigs and found that it was twice as fast-acting as traditional insulin.